- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Sacramento, CA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Ascendis Pharma (Palo Alto, CA)
- …United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology . Here at Ascendis, we pride ourselves on exceptional science, visionary ... improve the quality of Adverse Event intake. + Performs late case investigation and risk mitigation strategy. Ability to...case investigation and risk mitigation strategy. Ability to review late case(s) to determine Root Cause Analysis (RCA) and… more
- Ascendis Pharma (Palo Alto, CA)
- …United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology . Here at Ascendis, we pride ourselves on exceptional science, visionary ... improve the quality of Adverse Event intake. + Performs late case investigation and risk mitigation strategy. Ability to...case investigation and risk mitigation strategy. Ability to review late case(s) to determine Root Cause Analysis (RCA) and… more
- Bristol Myers Squibb (San Diego, CA)
- …proof of concept trials and will assure a seamless transition into late stage development (Phase II-III trials.) **Governance Participation and Signature Authority** ... since this position has responsibility for strategy and clinical research in oncology in multiple geographies + Experience interacting with business development and… more